BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22936064)

  • 21. Terminal deoxynucleotidyl transferase expression in acute myelogenous leukemia and myelodysplasia as determined by flow cytometry.
    Huh YO; Smith TL; Collins P; Bueso-Ramos C; Albitar M; Kantarjian HM; Pierce SA; Freireich EJ
    Leuk Lymphoma; 2000 Apr; 37(3-4):319-31. PubMed ID: 10752983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of correlation between immunoglobulin and T cell receptor gene rearrangements and TdT expression in acute myeloid leukaemia.
    Davey G; Bradstock KF; Kefford RF; Wishart Y; Kabral A; Grimsley P; Hughes WG
    Leuk Res; 1990; 14(1):77-83. PubMed ID: 1689438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute myeloblastic leukemia with minimal myeloid differentiation: phenotypical and ultrastructural characteristics.
    Villamor N; Zarco MA; Rozman M; Ribera JM; Feliu E; Montserrat E
    Leukemia; 1998 Jul; 12(7):1071-5. PubMed ID: 9665192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression profiling of minimally differentiated acute myeloid leukemia: M0 is a distinct entity subdivided by RUNX1 mutation status.
    Silva FP; Swagemakers SM; Erpelinck-Verschueren C; Wouters BJ; Delwel R; Vrieling H; van der Spek P; Valk PJ; Giphart-Gassler M
    Blood; 2009 Oct; 114(14):3001-7. PubMed ID: 19666867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
    Adriaansen HJ; Jacobs BC; Kappers-Klunne MC; Hählen K; Hooijkaas H; van Dongen JJ
    Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. De Novo Acute Myeloid Leukemia in Adults: Suppression of MicroRNA-223 is Independent of LMO2 Protein Expression BUT Associate With Adverse Cytogenetic Profile and Undifferentiated Blast Morphology.
    Akhter A; Patel JL; Farooq F; Qureshi A; Taher-Rad MS; Elyamany G; Al-Zahrani AM; Rashid-Kolvear F; Mansoor A
    Appl Immunohistochem Mol Morphol; 2015; 23(10):733-9. PubMed ID: 25710580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct association of RUNX family expression with genetic alterations and clinical outcome in acute myeloid leukemia.
    Zhao Y; Zhang T; Zhao Y; Zhou J
    Cancer Biomark; 2020; 29(3):387-397. PubMed ID: 32741803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of myeloperoxidase gene expression in minimally differentiated acute myelogenous leukemia (AML-M0) using in situ hybridization.
    Traweek ST; Liu J; Braziel RM; Johnson RM; Byrnes RK
    Diagn Mol Pathol; 1995 Sep; 4(3):212-9. PubMed ID: 7493141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNTT activation, TdT-aided gene length mutation, and better prognosis in ATG-based regimen allo-HSCT in AML.
    Zhou X; Nie D; Zhang Y; Liu Z; Zhao Y; Zhang J; Wang F; Fang J; Cao P; Chen X; Ma X; Yuan L; Chen J; Tan Y; Chen Q; Liu M; Liu M; Liu Y; Wu Q; Lu P; Liu H
    Mol Carcinog; 2023 May; 62(5):665-675. PubMed ID: 36752333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data.
    Kaleem Z; Crawford E; Pathan MH; Jasper L; Covinsky MA; Johnson LR; White G
    Arch Pathol Lab Med; 2003 Jan; 127(1):42-8. PubMed ID: 12521365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group.
    Gaidzik VI; Bullinger L; Schlenk RF; Zimmermann AS; Röck J; Paschka P; Corbacioglu A; Krauter J; Schlegelberger B; Ganser A; Späth D; Kündgen A; Schmidt-Wolf IG; Götze K; Nachbaur D; Pfreundschuh M; Horst HA; Döhner H; Döhner K
    J Clin Oncol; 2011 Apr; 29(10):1364-72. PubMed ID: 21343560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical review on features and cytogenetic patterns in adult acute myeloid leukemia with lymphoid markers.
    Cuneo A; Ferrant A; Michaux JL; Boogaerts M; Demuynck H; Bosly A; Doyen C; Carli MG; Piva N; Castoldi G
    Leuk Lymphoma; 1993 Mar; 9(4-5):285-91. PubMed ID: 8348065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of terminal deoxynucleotidyl transferase expression identifies a subset of high-risk adult T-lymphoblastic leukemia/lymphoma.
    Zhou Y; Fan X; Routbort M; Cameron Yin C; Singh R; Bueso-Ramos C; Thomas DA; Milton DR; Medeiros LJ; Lin P
    Mod Pathol; 2013 Oct; 26(10):1338-45. PubMed ID: 23702731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene mutation patterns in patients with minimally differentiated acute myeloid leukemia.
    Kao HW; Liang DC; Wu JH; Kuo MC; Wang PN; Yang CP; Shih YS; Lin TH; Huang YH; Shih LY
    Neoplasia; 2014 Jun; 16(6):481-8. PubMed ID: 25022553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trisomy 11 as an isolated abnormality in acute myeloid leukemia is associated with unfavorable prognosis but not with an NPM1 or KIT mutation.
    Alseraye FM; Zuo Z; Bueso-Ramos C; Wang S; Medeiros LJ; Lu G
    Int J Clin Exp Pathol; 2011 Apr; 4(4):371-7. PubMed ID: 21577323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of terminal transferase activity and glucocorticoid receptor levels in acute myeloid leukemia.
    Skoog L; Ost A; Biberfeld P; Christensson B; Hast R; Lagerlöf B; Nordenskjöld B; Reizenstein P
    Br J Cancer; 1984 Oct; 50(4):443-9. PubMed ID: 6593093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Terminal transferase positive acute myeloid leukemia: immunophenotypic characterization and response to induction therapy.
    Lo Coco F; Lopez M; Pasqualetti D; Montefusco E; Cafolla A; Monarca B; Sgadari C; De Rossi G
    Hematol Oncol; 1989; 7(2):167-74. PubMed ID: 2646199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rearrangement of immunoglobulin and T cell antigen receptor genes in acute myeloid leukemia with lymphoid-associated markers.
    Norton JD; Campana D; Hoffbrand AV; Janossy G; Coustan-Smith E; Jani H; Yaxley JC; Prentice HG
    Leukemia; 1987 Nov; 1(11):757-61. PubMed ID: 3500372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations.
    Tang JL; Hou HA; Chen CY; Liu CY; Chou WC; Tseng MH; Huang CF; Lee FY; Liu MC; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Lin LI; Tien HF
    Blood; 2009 Dec; 114(26):5352-61. PubMed ID: 19808697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous or sequential expression of lymphoid and myeloid phenotypes in acute leukemia.
    Neame PB; Soamboonsrup P; Browman G; Barr RD; Saeed N; Chan B; Pai M; Benger A; Wilson WE; Walker IR
    Blood; 1985 Jan; 65(1):142-8. PubMed ID: 3880643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.